Pembrolizumab: Powder for injection 50 mg, Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 5 July 2019 Public Summary Document (PSD) March 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) March 2019 PBAC Meeting - (Word 181KB)